- Around 2,400 people were diagnosed with laryngeal cancer in the UK in 2011, that’s more than 6 people every day.
- Laryngeal cancer is more than four times more common in men than in women. Around 1,900 men and 400 women were diagnosed with laryngeal cancer in the UK in 2011.
- Laryngeal cancer incidence rates in men rose until the early 1990s and have steadily fallen since then. Current incidence rates in men are lower than in the mid-1970s.
- Laryngeal cancer incidence rates in women rose until the late 1980s and have steadily fallen since then. Current incidence rates in women are similar to those in the mid-1970s.
- Laryngeal cancer is rarely diagnosed in people aged under 40. Nearly three quarters of cases in people aged 60 and over.
- In Europe, around 39,900 new cases of laryngeal cancer were estimated to have been diagnosed in 2012. The UK incidence rate is seventh lowest in Europe for males and 15th highest for females.
- Worldwide around 157,000 new cases of laryngeal cancer were estimated to have been diagnosed in 2012, with incidence rates varying across the world.
Laryngeal cancer statistics
New cases of laryngeal cancer, 2011, UK
Deaths from laryngeal cancer, 2012, UK
Survive laryngeal cancer for 10 or more years (males only), 2010-11, England and Wales
Preventable cases of laryngeal cancer, UK
- In 2012 around 780 people in the UK died from laryngeal cancer.
- Over the last decade laryngeal cancer death rates in men have fallen by a quarter; in women, they have fallen by a sixth.
- Around 8 in 10 laryngeal cancer deaths occur in men. In 2012, around 620 men died from laryngeal cancer, compared with around 170 women.
- Worldwide, around 83,400 people were estimated to have died from laryngeal cancer in 2012, with mortality rates varying across the world.
- In Europe, around 19,800 people were estimated to have died from laryngeal cancer in 2012. The UK mortality rate is sixth lowest in Europe for males and 20th highest for females.
- Overall, 7 in 10 men with laryngeal cancer survive the disease for five years or more.
- More than 6 in 10 men diagnosed with laryngeal cancer will survive the disease for ten years or more.
- Survival for laryngeal cancer is highest in the youngest men – more than three-quarters of men diagnosed aged 15-49 survive their disease for at least five years.
- Survival for laryngeal cancer is improving – now, 7 in 10 men survive for at least five years, compared with more than 5 in 10 forty years ago.
- 93% of laryngeal cancer cases each year in the UK are linked to major lifestyle and other risk factors.
- A person’s risk of developing laryngeal cancer depends on many factors, including age, genetics, and exposure to risk factors (including some potentially avoidable lifestyle factors).
- Smoking is the main avoidable risk factor for laryngeal cancer, linked to an estimated 79% of laryngeal cancer cases in the UK.
- An estimated 93% of laryngeal cancers in the UK are linked to lifestyle factors including smoking, and alcohol (25%).
- Certain occupational exposures cause laryngeal cancer.
- A diet high in fruit and vegetables may protect against laryngeal cancer – insufficient fruit and vegetables intake is linked to an estimated 45% of laryngeal cancer cases in the UK.
- HPV infection, environmental tobacco smoke, and certain medical conditions may relate to higher laryngeal cancer risk, but evidence is unclear.
- ‘Two-week wait’ and ’31-day wait’ standards are met by all countries, and ‘62-day wait’ is not met by any country for head and neck cancers.
The latest statistics available for laryngeal cancer in the UK are; incidence 2011, mortality 2012 and survival 2010-2011.
Survival statistics give an overall picture of survival and (unless otherwise stated) include all adults (15-99) diagnosed, at all ages,
Due to the small numbers of women diagnosed with laryngeal cancer each year, most of the survival data refers to males only.
Survival by stage is not yet routinely available for the UK due to inconsistencies in the collecting and recording of staging data in the past. Survival by stage is available for the former Anglia Cancer Network in the east of England, however. The former Anglia Cancer Network covers around 5% of the population of England and may not be representative of the country as a whole due to differences in underlying demographic factors (such as age, deprivation or ethnicity), as well as variation in local healthcare provision standards and policies.
Cancer waiting times statistics are for patients who entered the health care system within financial year 2014-15. Laryngeal cancer is part of the group 'Head and Neck cancers' for cancer waiting times data. Codes vary per country but broadly include: lip, tongue, gum, floor of mouth, palate, other and unspecified parts of mouth, parotid gland, salivary glands, tonsil, oropharynx, nasopharynx, piriform sinus, hypopharynx, other ill-defined site of lip, oral cavity and pharynx, nasal cavity and middle ear, accessory sinuses, larynx, thyroid and lymph nodes and other and ill-defined sites of the head, face and neck.
You are welcome to reuse this Cancer Research UK statistics content for your own work.
Credit us as authors by referencing Cancer Research UK as the primary source. Suggested styles are:
Web content: Cancer Research UK, full URL of the page, Accessed [month] [year].
Publications: Cancer Research UK ([year of publication]), Name of publication, Cancer Research UK.